Abbott Laboratories (ABT)

• Annual Data
• Quarterly Data

Abbott Laboratories, Common-Size Consolidated Income Statement

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net sales
	Cost of products sold, excluding amortization of intangible assets
	Amortization of intangible assets
	Gross profit
	Research and development
	Selling, general and administrative
	Operating earnings
	Interest expense
	Interest income
	Net foreign exchange gain (loss)
	Debt extinguishment costs
	Other income (expense), net
	Earnings from continuing operations before taxes
	Taxes on earnings from continuing operations
	Earnings from continuing operations
	Earnings from discontinued operations, net of taxes
	Gain on sale of discontinued operations, net of taxes
	Net earnings from discontinued operations, net of taxes
	Net earnings

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).